GR70235B - - Google Patents

Info

Publication number
GR70235B
GR70235B GR63034A GR800163034A GR70235B GR 70235 B GR70235 B GR 70235B GR 63034 A GR63034 A GR 63034A GR 800163034 A GR800163034 A GR 800163034A GR 70235 B GR70235 B GR 70235B
Authority
GR
Greece
Prior art keywords
lower alkyl
alkyl
hydrogen
represents hydrogen
tetrahydrofurylmethyl
Prior art date
Application number
GR63034A
Other languages
English (en)
Inventor
Alan Chapman White
Edwin Trevor Edington
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of GR70235B publication Critical patent/GR70235B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Lubricants (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
GR63034A 1979-10-20 1980-10-02 GR70235B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7936502 1979-10-20

Publications (1)

Publication Number Publication Date
GR70235B true GR70235B (el) 1982-09-01

Family

ID=10508675

Family Applications (1)

Application Number Title Priority Date Filing Date
GR63034A GR70235B (el) 1979-10-20 1980-10-02

Country Status (17)

Country Link
US (1) US4360519A (el)
EP (1) EP0027695B1 (el)
JP (1) JPS5665880A (el)
KR (2) KR840002427B1 (el)
AT (1) ATE4980T1 (el)
AU (1) AU531586B2 (el)
CA (1) CA1126731A (el)
DE (1) DE3065304D1 (el)
DK (1) DK151800C (el)
ES (1) ES8107201A1 (el)
FI (1) FI803277L (el)
GB (1) GB2061272B (el)
GR (1) GR70235B (el)
IE (1) IE50355B1 (el)
MY (1) MY8500468A (el)
PT (1) PT71940B (el)
ZA (1) ZA806017B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2125793B (en) * 1982-08-19 1985-10-02 Wyeth John & Brother Ltd Morpholine derivatives
GB8305638D0 (en) * 1983-03-01 1983-03-30 Wyeth John & Brother Ltd Morpholine derivatives
FR2553412B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8418657D0 (en) * 1984-07-21 1984-08-22 Beecham Group Plc Compounds
FR2581383A1 (fr) * 1985-05-03 1986-11-07 Cerm Cent Europ Rech Mauvernay 2-alkyl-2-aryl morpholines substituees, leur preparation et les compositions pharmaceutiques les contenant
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US6048859A (en) * 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
US7348456B2 (en) * 2002-12-19 2008-03-25 Merck & Co., Inc. Substituted amides
ES2571220T3 (es) 2003-06-17 2016-05-24 Arena Pharm Inc Clorhidrato de 8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepina
CA2646044A1 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
SG177128A1 (en) 2006-12-05 2012-01-30 Arena Pharm Inc Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
AU2011255276B2 (en) 2010-05-21 2016-09-22 Research Triangle Institute Phenylmorpholines and analogues thereof
AU2011255456B2 (en) 2010-05-21 2017-01-19 Dignity Health Doing Business As St. Joseph's Hospital And Medical Center And Barrow Neurological Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2012030957A2 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
MX2013002418A (es) 2010-09-01 2013-08-01 Arena Pharm Inc Administracion de lorcaserina a individuos con daño renal.
MX2013002422A (es) 2010-09-01 2013-05-17 Arena Pharm Inc Sales de lorcaserina con acidos opticamente activos.
CN103189053A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 用于体重控制的5-ht2c激动剂的调节释放剂型
MY181736A (en) 2012-10-09 2021-01-05 Arena Pharm Inc Method of weight management

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997469A (en) * 1961-08-22 Preparation of substituted
US2835669A (en) * 1958-05-20 Process for the production of substi-
US3112311A (en) * 1957-04-05 1963-11-26 Geigy Chem Corp 2-phenyl-5, 6-dimethyl-morpholines and 2-phenyl-5, 6-tetramethylene-morpholines
US3296076A (en) * 1962-06-11 1967-01-03 Boehringer Sohn Ingelheim Pilomotor shaving compositions and method of using same
GB1336732A (en) * 1970-10-28 1973-11-07 Istituto Gentili Spa Pisa Diethanolamine derivatives
GB1452701A (en) * 1974-05-07 1976-10-13 Ici Ltd Morpholine derivatives

Also Published As

Publication number Publication date
CA1126731A (en) 1982-06-29
ES496074A0 (es) 1981-10-01
MY8500468A (en) 1985-12-31
FI803277L (fi) 1981-04-21
DE3065304D1 (en) 1983-11-17
GB2061272A (en) 1981-05-13
PT71940A (en) 1980-11-01
KR840002428B1 (ko) 1984-12-27
IE50355B1 (en) 1986-04-02
JPS5665880A (en) 1981-06-03
US4360519A (en) 1982-11-23
ZA806017B (en) 1982-04-28
ES8107201A1 (es) 1981-10-01
KR840002427B1 (ko) 1984-12-27
GB2061272B (en) 1983-08-10
EP0027695B1 (en) 1983-10-12
DK441080A (da) 1981-04-21
DK151800B (da) 1988-01-04
KR830004277A (ko) 1983-07-09
ATE4980T1 (de) 1983-10-15
PT71940B (pt) 1981-08-31
DK151800C (da) 1988-06-06
IE801995L (en) 1981-04-20
EP0027695A1 (en) 1981-04-29
AU6292280A (en) 1981-04-30
AU531586B2 (en) 1983-09-01

Similar Documents

Publication Publication Date Title
GB2061272B (en) Morpholine derivatives
ES485163A1 (es) Procedimiento de preparacion de un nuevo derivado 5h-2,3- benzodiazepinos o de una sal de adicion acida
ES468119A1 (es) Un procedimiento para la preparacion de triazinas
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
ES476343A1 (es) Procedimiento para la obtencion de ciclopentan-1-aminas
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
SE8100403L (sv) Cyklohexen-derivat
GB2108495B (en) Triazoloquinazolone derivatives
ES455741A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
ES8401456A1 (es) Procedimiento para la preparacion de 2-aminometilfenoles.
ES8401952A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
FI871253A0 (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
ES462838A1 (es) Procedimiento para la preparacion de compuestos tetracicli- cos biologicamente activos.
JPS5538397A (en) Diuretic drug
ES8103047A1 (es) Procedimiento de preparacion de derivados aminoisoquinolinosasi como de sus sales de adicion acidas, farmaceuticamente aceptables y de sus derivados amonicos cuaternarios
ES8302734A1 (es) Procedimiento para preparar 5'-n-(aminoalquil)-amino-5'-deo-xiadenosina
ES457996A1 (es) Un procedimiento para la preparacion de nuevos derivados de morfolina.
NO833978L (no) Fremgangsmaate for fremstilling av terapeutisk aktive semikarbazid-derivater
GB2007655A (en) Aryl ethers of N-alkyl- piperidines and acid addition salts thereof